Cortese Bernardo, di Palma Gaetano, Latini Roberto
Interventional Cardiology, ASST Fatebenefratelli-Sacco, Milano, Italy.
Catheter Cardiovasc Interv. 2018 Jun;91(7):1291-1293. doi: 10.1002/ccd.27549. Epub 2018 Feb 26.
Coronary Sinus Reducer (Neovasc, Inc., Richmond B.C., Canada) has shown to be an effective and safe treatment option for the treatment of refractory angina. Until now, a few number of complications related to its implantation have been reported. Coronary sinus perforation is a rare complication, more often related to cardiac surgery procedures. We report the first case of coronary sinus perforation after a sinus Reducer implantation.
冠状动脉窦减压器(Neovasc公司,加拿大不列颠哥伦比亚省里士满)已被证明是治疗顽固性心绞痛的一种有效且安全的治疗选择。到目前为止,已报告了一些与其植入相关的并发症。冠状动脉窦穿孔是一种罕见的并发症,更常与心脏外科手术相关。我们报告了首例冠状动脉窦减压器植入术后冠状动脉窦穿孔的病例。